申请人:MERZ PHARMA GMBH & CO KGAA
公开号:WO2013030358A1
公开(公告)日:2013-03-07
The invention relates to 4-aminonaphthalene-2-carboxylic acids and 1-amino- isoquinoline-3-carboxylic acids as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
本发明涉及4-氨基萘-2-羧酸和1-氨基异喹啉-3-羧酸以及它们的药用盐。该发明还涉及一种制备这些化合物的方法。本发明的化合物是甘氨酸B拮抗剂,因此对于控制和预防各种疾病,包括神经系统疾病,是有用的。